Effect of diet and exercise on serum insulin, IGF-I, and IGFBP-1 levels and growth of LNCaP cells in vitro (United States)

被引:96
作者
Ngo, TH
Barnard, RJ
Tymchuk, CN
Cohen, P
Aronson, WJ
机构
[1] Univ Calif Los Angeles, Dept Physiol Sci, Los Angeles, CA 90095 USA
[2] Univ Calif Los Angeles, Dept Pediat, Los Angeles, CA 90095 USA
[3] Univ Calif Los Angeles, Dept Urol, Los Angeles, CA 90095 USA
关键词
apoptosis; dietary fat; IGF-I axis; physical activity; prostate cancer;
D O I
10.1023/A:1021911517010
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective: Accumulating evidence indicates that prostate cancer is associated with high levels of serum IGF-I. This study was conducted to determine whether a low-fat diet and exercise (DE) intervention may modulate the IGF axis and reduce prostate cancer cell growth in vitro. Methods: Fasting serum was obtained from 14 men (age 60 +/- 3 years) participating in an 11-day DE program and from eight similarly aged men who had followed the DE program for 14.2 +/- 1.7 years (long-term). Insulin, IGF-I, IGFBP-1, and IGFBP-3 were measured by ELISA, and serum was used to stimulate LNCaP cell growth in vitro. Results: Serum IGF-I levels decreased by 20% while IGFBP-1 increased by 53% after 11-day DE. In the long-term group, IGF-I was 55% lower, while IGFBP-1 was 150% higher relative to baseline. Serum insulin decreased by 25% after 11-day DE and was 68% lower in the long-term group, relative to baseline. No changes in serum IGFBP-3 were observed. Serum-stimulated LNCaP cell growth was reduced by 30% in post-11-day serum and by 44% in long-term serum relative to baseline. LNCaP cells incubated with post-DE serum showed increased apoptosis/necrosis, compared to baseline. Conclusions: A low-fat diet and exercise intervention induces in-vivo changes in the circulating IGF axis and is associated with reduced growth and enhanced apoptosis/necrosis of LNCaP tumor cells in vitro.
引用
收藏
页码:929 / 935
页数:7
相关论文
共 40 条
[11]   Dietary fat and prostate cancer progression and survival [J].
Fradet, Y ;
Meyer, F ;
Bairati, I ;
Shadmani, R ;
Moore, L .
EUROPEAN UROLOGY, 1999, 35 (5-6) :388-391
[12]   A PROSPECTIVE-STUDY OF DIETARY-FAT AND RISK OF PROSTATE-CANCER [J].
GIOVANNUCCI, E ;
RIMM, EB ;
COLDITZ, GA ;
STAMPFER, MJ ;
ASCHERIO, A ;
CHUTE, CC ;
WILLETT, WC .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (19) :1571-1579
[13]   THE BULK-FLOW HYPOTHESIS - NOT QUITE THE END [J].
GRIFFITHS, G ;
DOMS, RW ;
MAYHEW, T ;
LUCOCQ, J .
TRENDS IN CELL BIOLOGY, 1995, 5 (01) :9-13
[14]  
HAENSZEL W, 1968, JNCI-J NATL CANCER I, V40, P43
[15]  
HARP J, 1989, CLIN RES, V37
[16]   INSULIN-LIKE GROWTH FACTOR-I - ACTION AND RECEPTOR CHARACTERIZATION IN HUMAN PROSTATE-CANCER CELL-LINES [J].
IWAMURA, M ;
SLUSS, PM ;
CASAMENTO, JB ;
COCKETT, ATK .
PROSTATE, 1993, 22 (03) :243-252
[17]  
Kaplan PJ, 1999, CANCER RES, V59, P2203
[18]  
KATZ LEL, 1995, ENDOCRINOLOGIST, V5, P36
[19]  
KONDO Y, 1994, CANCER RES, V54, P6129
[20]   MOLECULAR AND CELLULAR ASPECTS OF THE INSULIN-LIKE GROWTH-FACTOR-I RECEPTOR [J].
LEROITH, D ;
WERNER, H ;
BEITNERJOHNSON, D ;
ROBERTS, CT .
ENDOCRINE REVIEWS, 1995, 16 (02) :143-163